Endometriosis Treatment: Nanoparticle‐Based Platform for Activatable Fluorescence Imaging and Photothermal Ablation of Endometriosis (Small 18/2020)

In: Small · 2020 · vol. 16(18) · doi:10.1002/smll.202070101 · W3021841894
article OA: bronze CC0
AI-generated summary by claude@2026-06, 2026-06-12

Photo-responsive nanoparticles were developed to delineate endometriosis with fluorescence imaging and ablate it via photothermal therapy in mouse models.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In article number 1906936, Ov D. Slayden, Oleh Taratula, and co-workers present a nanomedicine approach for endometriosis treatment. Photo-responsive nanoparticles concurrently delineate and ablate endometriosis tissue xenografts in mice employing real-time fluorescence imaging and photothermal therapy. Following intravenous injection, nanoparticles activate their fluorescence in endometriotic lesions. Excitation by near-infrared light produces heat within endometriotic tissues, resulting in their complete eradication. This approach could aid surgeons in identifying and eliminating endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK